Amgen News
Most Popular Amgen Story
Amgen plots D-mab launch with fewer reps
Was Amgen CEO Kevin Sharer (photo) a Boy Scout? The company certainly obeys the old Scout motto. It's already preparing for the launch of denosumab, the potential blockbuster bone drug, even though... Read more...
Latest Headlines
- November 10, 2008
- November 7, 2008
- October 23, 2008
- October 3, 2008
- September 29, 2008
- September 19, 2008
- September 10, 2008
- August 28, 2008
- August 19, 2008
- August 6, 2008
- July 31, 2008
- July 30, 2008
- July 29, 2008
- July 14, 2008
- July 14, 2008
- June 27, 2008
- June 17, 2008
- May 2, 2008
- April 28, 2008
- April 25, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
